Medicamen Biotech Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Medicamen Biotech Ltd is ₹ 229.45 as of 12 Jun 15:30 . The P/E Ratio of Medicamen Biotech Ltd changed from 53.8 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Torrent Pharmaceuticals Ltd changed from 34.3 on March 2021 to 66 on March 2026 . This represents a CAGR of 11.53% over 6 years The Market Cap of Medicamen Biotech Ltd changed from ₹ 652.37 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Torrent Pharmaceuticals Ltd changed from ₹ 43002 crore on March 2021 to ₹ 142845 crore on March 2026 . This represents a CAGR of 22.15% over 6 years The revenue of Medicamen Biotech Ltd for the Mar '26 is ₹ 62.38 crore as compare to the Dec '25 revenue of ₹ 47.44 crore. This represent the growth of 31.49% The revenue of Torrent Pharmaceuticals Ltd for the Mar '26 is ₹ 4180 crore as compare to the Dec '25 revenue of ₹ 3290 crore. This represent the growth of 27.05% The ebitda of Medicamen Biotech Ltd for the Mar '26 is ₹ 7.18 crore as compare to the Dec '25 ebitda of ₹ 4.91 crore. This represent the growth of 46.23% The ebitda of Torrent Pharmaceuticals Ltd for the Mar '26 is ₹ 1273 crore as compare to the Dec '25 ebitda of ₹ 1065 crore. This represent the growth of 19.53% The net profit of Medicamen Biotech Ltd changed from ₹ 0.8 crore to ₹ 4.45 crore over 8 quarters. This represents a CAGR of 135.85% The net profit of Torrent Pharmaceuticals Ltd changed from ₹ 457 crore to ₹ 364 crore over 8 quarters. This represents a CAGR of -10.75% The Dividend Payout of Medicamen Biotech Ltd changed from 9.78 % on March 2021 to 0 % on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of Torrent Pharmaceuticals Ltd changed from 52.06 % on March 2021 to 58.69 % on March 2026 . This represents a CAGR of 2.02% over 6 years .

About Medicamen Biotech Ltd

A diversified enterprise, Medicamen Biotech Limited (MBL) is a research-led pharmaceutical company involved in developing, manufacturing and marketing of finished dosage formulations for domestic as well as international markets.
The Company has presence over 35+ countries.
Its offerings include Finished Dosage Forms (FDF's) to African countries. In India, MBL is among the leading companies in oncology segment with its own sales force and a branding team that has helped garner a strong foothold in the domestic market.
MBL has three pharma formulation facilities including two in Haridwar (Uttarakhand), one in Bhiwadi (Rajasthan).
The Company manufactures products across various therapeutic categories including Pain Management, Cough & Cold, Cardiovascular & Central Nervous System, Anti-Diabetic, Gastrointestinal, Anti-Allergic among others.

About Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Limited is a leading player in the Indian pharmaceutical sector, concentrating on the chronic and sub-chronic therapeutic segments.
The Company has established itself as a leader in developing niche pharmaceutical solutions through its patient-centric innovation.
The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India.
It has a strong international presence across more than 40 countries with operations in regulated and emerging markets, such as the US, Europe, Germany, Brazil and Rest of the World. The Company operates through its wholly-owned subsidiaries spread across 15 countries with major setups in the US, Germany and Brazil.

FAQs for the comparison of Medicamen Biotech Ltd and Torrent Pharmaceuticals Ltd

Which company has a larger market capitalization, Medicamen Biotech Ltd or Torrent Pharmaceuticals Ltd?

Market cap of Medicamen Biotech Ltd is 311 Cr while Market cap of Torrent Pharmaceuticals Ltd is 154,837 Cr

What are the key factors driving the stock performance of Medicamen Biotech Ltd and Torrent Pharmaceuticals Ltd?

The stock performance of Medicamen Biotech Ltd and Torrent Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Medicamen Biotech Ltd and Torrent Pharmaceuticals Ltd?

As of June 15, 2026, the Medicamen Biotech Ltd stock price is INR ₹229.45. On the other hand, Torrent Pharmaceuticals Ltd stock price is INR ₹4574.95.

How do dividend payouts of Medicamen Biotech Ltd and Torrent Pharmaceuticals Ltd compare?

To compare the dividend payouts of Medicamen Biotech Ltd and Torrent Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.